Performance of a Limiting-Antigen Avidity Enzyme Immunoassay for Cross-Sectional Estimation of HIV Incidence in the United States

BACKGROUND: A limiting antigen avidity enzyme immunoassay (HIV-1 LAg-Avidity assay) was recently developed for cross-sectional HIV incidence estimation. We evaluated the performance of the LAg-Avidity assay alone and in multi-assay algorithms (MAAs) that included other biomarkers. METHODS AND FINDIN...

Descripción completa

Detalles Bibliográficos
Autores principales: Konikoff, Jacob, Brookmeyer, Ron, Longosz, Andrew F., Cousins, Matthew M., Celum, Connie, Buchbinder, Susan P., Seage, George R., Kirk, Gregory D., Moore, Richard D., Mehta, Shruti H., Margolick, Joseph B., Brown, Joelle, Mayer, Kenneth H., Koblin, Beryl A., Justman, Jessica E., Hodder, Sally L., Quinn, Thomas C., Eshleman, Susan H., Laeyendecker, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873916/
https://www.ncbi.nlm.nih.gov/pubmed/24386116
http://dx.doi.org/10.1371/journal.pone.0082772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873916/
https://www.ncbi.nlm.nih.gov/pubmed/24386116
http://dx.doi.org/10.1371/journal.pone.0082772

Ejemplares similares